SCHEMBL214929

SCHEMBL214929

Cn1ccnc1-n1nc(N)c2ccccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIMK1 P53667 1/20 0.37
BRD4 O60885 1/20 0.36
TTK P33981 6/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 3/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MAPT P10636 2/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
SCN9A Q15858 1/20 0.33
PRKD3 O94806 1/20 0.33
PRKD1 Q15139 1/20 0.33
PRKD2 Q9BZL6 1/20 0.33
TSHR P16473 1/20 0.33
RAB9A P51151 1/20 0.33
GSK3B P49841 1/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL216606 0.74 BRD4 (0.39) BRD4ALDH1A1MAPTHTR2AHTR2C
SCHEMBL17463116 0.74 GPR3 (0.43) BRD4KDM4EALDH1A1MAPTRXFP1
SCHEMBL18131343 0.71 RAB9A (0.47) LIMK1TTKMAPTSCN9APRKD3
SCHEMBL10831975 0.70 MAPT (0.47) TTKKDM4EALDH1A1HSD17B10MAPT
SCHEMBL25222249 0.69 KHK (0.40) TTKMAPTSCN9A
SCHEMBL823488 0.69 GSK3B (0.45) LIMK1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL25678127 0.68 ADORA3 (0.48) KDM4EALDH1A1HPGDMAPTSCN9A
SCHEMBL216173 0.68 CYP17A1 (0.42) LIMK1TTKKDM4EALDH1A1HPGD
SCHEMBL25229098 0.68 CYP17A1 (0.45) TTKALDH1A1HPGDHSD17B10SCN9A
SCHEMBL18131341 0.67 PDE10A (0.40) LIMK1BRD4TTKALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8288396-B2 Pyrimidopyrimidoindazole derivative MSDKK (JP) 2012-10-16 US disclosed
US-20120134955-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE MSD K.K. (JP) 2012-05-31 US disclosed
EP-2401281-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE MSD K.K. (JP) 2012-01-04 EP disclosed
WO-2010098367-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE BANYU PHARMACEUTICAL CO.,LTD. (JP) 2010-09-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120134955-A1 PYRIMIDOPYRIMIDOINDAZOLE DERIVATIVE WEE1, WEE2, DCK LIMK1 746/4885BRD4 1149/4885TTK 27/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.